Mod­er­na goes af­ter Al­ny­lam, fil­ing coun­ter­claims in Spike­vax patent suit

Mod­er­na has gone on the of­fen­sive in its patent feud against Al­ny­lam, fil­ing two coun­ter­claims against the RNAi drug de­vel­op­er af­ter Al­ny­lam’s patent suit. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER